These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8483888)

  • 41. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW; Koivurinne K
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Leu-M1, CEA and intermediate filament proteins in histochemical differential diagnosis of malignant pleural mesothelioma].
    Heckmayr M; Gatzmeier U; Schröder S; Niendorf A; Fasske E
    Pneumologie; 1990 Feb; 44 Suppl 1():618-9. PubMed ID: 2195531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks.
    Kim JH; Kim GE; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Diagn Cytopathol; 2009 Apr; 37(4):258-61. PubMed ID: 19217030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.
    Mimura T; Ito A; Sakuma T; Ohbayashi C; Yoshimura M; Tsubota N; Okita Y; Okada M
    Cancer; 2007 Mar; 109(5):933-8. PubMed ID: 17279584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunocytological staining reactions of anti-carcinoembryonic antigen, Ca, and anti-human milk fat globule monoclonal antibodies on benign and malignant exfoliated mesothelial cells.
    Ghosh AK; Butler EB
    J Clin Pathol; 1987 Dec; 40(12):1424-7. PubMed ID: 3323250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic utility of D2-40 and podoplanin in effusion cell blocks.
    Bhalla R; Siddiqui MT; Mandich D; Cartun RW; Fiel-Gan MD; Nassar A; Mandavilli SR
    Diagn Cytopathol; 2007 Jun; 35(6):342-7. PubMed ID: 17497664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
    Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
    Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pseudomesotheliomatous adenocarcinoma of the lung. Immunohistochemical study with special reference to detection of blood group isoantigens and Ber-EP4 antigen].
    Moch H; Kiener S; Dalquen P; Gudat F
    Pathologe; 1993 Jan; 14(1):11-5. PubMed ID: 8095719
    [No Abstract]   [Full Text] [Related]  

  • 49. Application of immunocytochemistry to the cytologic study of peritoneal fluids in patients with ovarian cancer.
    Shinozuka T; Ebisawa K; Miyamoto T; Murakami M; Fujii A; Osamura Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1355-62. PubMed ID: 1955789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Image cytometry: an aid for cytological diagnosis of pleural effusions.
    Osterheld MC; Liette C; Anca M
    Diagn Cytopathol; 2005 Mar; 32(3):173-6. PubMed ID: 15690335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV; Nesland JM; Davidson B
    Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.
    Saleh HA; El-Fakharany M; Makki H; Kadhim A; Masood S
    Diagn Cytopathol; 2009 May; 37(5):324-32. PubMed ID: 19191294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis.
    Carella R; Deleonardi G; D'Errico A; Salerno A; Egarter-Vigl E; Seebacher C; Donazzan G; Grigioni WF
    Am J Surg Pathol; 2001 Jan; 25(1):43-50. PubMed ID: 11145250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The value of the immunoperoxidase slide assay in the diagnosis of malignant pleural effusions in breast cancer.
    Guzman J; Costabel U; Bross KJ; Wiehle U; Grunert F; Schaefer HE
    Acta Cytol; 1988; 32(2):188-92. PubMed ID: 3279712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions.
    Chen CJ; Chang SC; Tseng HH
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Sep; 54(3):149-55. PubMed ID: 7954054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Usefulness of ploidy, AgNOR and immunocytochemistry for differentiating benign and malignant cells in serous effusions.
    Palaoro LA; Blanco AM; Gamboni M; Rocher AE; Rotenberg RG
    Cytopathology; 2007 Feb; 18(1):33-9. PubMed ID: 17250601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of malignant cells in serous effusions using a panel of monoclonal antibodies Ber-EP4, MCA-b-12 and EMA.
    Stoop JA; Hendriks JG; Berends D
    Cytopathology; 1992; 3(5):297-302. PubMed ID: 1288655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The histopathological diagnosis of malignant mesothelioma v. pulmonary adenocarcinoma: reproducibility of the histopathological diagnosis.
    Skov BG; Lauritzen AF; Hirsch F; Nielsen HW
    Histopathology; 1994 Jun; 24(6):553-7. PubMed ID: 8063283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma.
    Brockstedt U; Gulyas M; Dobra K; Dejmek A; Hjerpe A
    Am J Clin Pathol; 2000 Aug; 114(2):203-9. PubMed ID: 10941335
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytopathology of malignant mesothelioma: a stepwise logistic regression analysis.
    Stevens MW; Leong AS; Fazzalari NL; Dowling KD; Henderson DW
    Diagn Cytopathol; 1992; 8(4):333-41. PubMed ID: 1638933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.